Redsense Medical AB (publ) (NGM:REDS)

Redsense Medical AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 16, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	100	117	107	133	345	628
Market Cap Growth	9.42%	9.42%	-19.83%	-61.46%	-44.97%	270.87%
Enterprise Value	84	101	100	119	319	623
Last Close Price	6.06	7.10	7.60	9.48	24.60	36.88
PE Ratio	291.39	341.40	-	-	-	-
PS Ratio	3.46	4.06	4.18	7.95	21.13	36.70
PB Ratio	2.52	2.95	4.62	4.90	9.21	8.57
P/TBV Ratio	2.52	2.95	4.62	4.90	9.21	8.57
EV/Sales Ratio	2.93	3.50	3.91	7.10	19.50	36.43
EV/EBITDA Ratio	16.66	19.90	-	-	-	-
EV/EBIT Ratio	-	481.77	-	-	-	-
Debt / Equity Ratio	-	-	-	-	0.07	-
Asset Turnover	0.84	0.84	0.89	0.45	0.27	0.35
Inventory Turnover	2.91	2.91	8.57	3.78	3.20	4.79
Quick Ratio	9.79	9.79	3.26	4.42	9.78	12.35
Current Ratio	12.66	12.66	3.88	5.03	10.34	12.85
Return on Equity (ROE)	1.09%	1.09%	-17.96%	-27.10%	-14.40%	-20.50%
Return on Assets (ROA)	0.38%	0.38%	-11.00%	-17.25%	-12.29%	-10.39%
Return on Capital (ROIC)	0.42%	0.42%	-12.53%	-18.98%	-13.23%	-11.36%
Return on Capital Employed (ROCE)	0.50%	0.50%	-	-	-	-
Earnings Yield	34.32%	0.29%	-4.23%	-6.58%	-2.31%	-1.44%
FCF Yield	-827.45%	-7.06%	-4.78%	-7.39%	-3.64%	-1.06%
Dividend Yield	-	-	-	-	-	5.80%
Buyback Yield / Dilution	-2125.00%	-21.25%	0.16%	-0.60%	-	-15.33%
Total Shareholder Return	-2125.00%	-21.25%	0.16%	-0.60%	-	-9.52%

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.